What is the recommended dosage and administration protocol for a Midazolam (Benzodiazepine) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam Infusion Dosage and Administration Protocol

For sedative-naïve adult patients requiring midazolam infusion, begin with a 2 mg intravenous bolus dose followed by a continuous infusion of 1 mg/h, with doses adjusted based on patient size, age, and organ dysfunction. 1

Adult Dosing Protocol

Initial Bolus Dose

  • For sedative-naïve patients: 2 mg IV bolus administered over 2-3 minutes 1
  • For patients with renal/hepatic impairment or elderly: Consider reducing initial bolus to 1-1.5 mg 2
  • Allow 3-5 minutes to evaluate sedative effect before additional dosing 2

Continuous Infusion Setup

  • Dilute midazolam 5 mg/mL to a concentration of 0.5 mg/mL with 0.9% sodium chloride or 5% dextrose in water 2
  • Initial infusion rate: 1 mg/h (0.02 mg/kg/h for a typical adult) 1
  • Maintenance range: 0.02-0.10 mg/kg/h (1-7 mg/h for a typical adult) 2

Titration Protocol

  • If patient becomes symptomatic during infusion, administer a bolus dose equal to or double the hourly infusion rate 1
  • Order IV bolus doses every 5 minutes as needed 1
  • If patient requires two bolus doses within an hour, double the infusion rate 1
  • Adjust infusion rate by 25-50% to maintain desired sedation level 2
  • Decrease rate by 10-25% every few hours to find minimum effective dose 2

Pediatric Dosing Protocol

Initial Bolus Dose

  • For sedation/anxiolysis: 0.05-0.10 mg/kg IV over 2-3 minutes (maximum: 5 mg) 1
  • For seizures: 0.15-0.20 mg/kg IV loading dose 1

Continuous Infusion

  • For children with intubated trachea: Start at 0.06-0.12 mg/kg/h (1-2 μg/kg/min) 2
  • For refractory status epilepticus: Start at 1 μg/kg/min, increase by increments of 1 μg/kg/min (maximum: 5 μg/kg/min) every 15 minutes until seizures stop 1, 3
  • Recent evidence suggests a therapeutic window of 2.0-5.0 μg/kg/min (0.12-0.30 mg/kg/h) may achieve earlier seizure cessation 3

Neonatal Dosing

  • For intubated neonates <32 weeks: 0.03 mg/kg/h (0.5 μg/kg/min) 2
  • For intubated neonates >32 weeks: 0.06 mg/kg/h (1 μg/kg/min) 2
  • Do not use loading doses in neonates 2

Monitoring Requirements

  • Continuous monitoring of vital signs and oxygen saturation 2
  • Assess sedation level at regular intervals using standardized sedation scales 4
  • Be prepared to provide respiratory support regardless of administration route 1
  • Have flumazenil available to reverse life-threatening respiratory depression 1
  • Monitor for hypotension, especially in hemodynamically compromised patients 2

Special Considerations

  • For elderly patients (>60 years) or those with organ dysfunction: Use lower doses (reduce by 25-50%) 2
  • When combined with opioids: Increased risk of respiratory depression; consider reducing midazolam dose by 25-30% 2
  • For withdrawal of life-sustaining measures: Titrate to symptoms with no specified dose limit 1
  • Non-benzodiazepine alternatives (propofol, dexmedetomidine) may be preferred for ICU sedation due to lower risk of delirium 1

Common Pitfalls to Avoid

  • Oversedation: Assess sedation level frequently and adjust dose accordingly 2, 4
  • Respiratory depression: Particularly when combined with other sedatives or opioids 1
  • Paradoxical agitation: May occur especially in younger children 1
  • Prolonged emergence: Due to accumulation with extended infusions, especially in renal/hepatic impairment 4
  • Delirium: Benzodiazepine use is a strong risk factor for ICU delirium 1

By following this protocol and adjusting doses based on individual patient response, midazolam infusions can be safely and effectively administered while minimizing adverse effects and optimizing patient outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.